Exhibit 99(e)(9) NONCOMPETITION, NONDISCLOSURE AND DEVELOPMENTS AGREEMENT This NONCOMPETITION, NONDISCLOSURE AND DEVELOPMENTS AGREEMENT (hereinafter the "Agreement") is entered into as of the 19th day of February 2002, by and between Charles M....And Developments Agreement • March 1st, 2002 • Digene Corp • In vitro & in vivo diagnostic substances • Maryland
EX-4 5 filename5.htm Execution Version AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Page - i - Schedule A - Schedule of Investors Schedule B - Schedule of Key Holders Exhibit A - Form of Noncompetition and Nonsolicitation Agreement - ii - AMENDED...And Developments Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 7th day of August, 2017, by and among Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any additional Investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
